LIR-containing proteins in Danio rerio>> EXPORT DATA
S.No. | Uniprot ID | Start | End | LIR Sequence | PSSM Score ▲ ▼ | Similar LIR Motifs | Molecular Function | Biological Process | Cellular Component |
2001 | F1R1R8 | 2501 | 2506 | GVFDLL | 7 | cell adhesion (GO:0007155) |
|||
2002 | F1R1W0 | 572 | 577 | DSYLTV | 14 | ||||
2003 | F1R1W1 | 308 | 313 | KEFDFL | 13 | ||||
2004 | F1R1X4 | 884 | 889 | LGFVTL | 11 | ||||
2005 | F1R1Z7 | 249 | 254 | EEFEVL | 14 | ||||
2006 | F1R209 | 246 | 251 | SSWTTL | 19 | BNI3L_HUMAN(34-39) SSWVEL(4) | |||
2007 | F1R210 | 77 | 82 | KGYLKI | 11 | nucleic acid binding (GO:0003676) |
|||
2008 | F1R218 | 367 | 372 | RVFVDL | 8 | ||||
2009 | F1R226 | 1097 | 1102 | GSFDEL | 12 | ||||
2010 | F1R226 | 1200 | 1205 | LEFLAV | 9 | ||||
2011 | F1R227 | 259 | 264 | RDYDDI | 17 | ||||
2012 | F1R253 | 763 | 768 | RGFTPL | 11 | ||||
2013 | F1R253 | 1046 | 1051 | PEFTML | 13 | ||||
2014 | F1R256 | 1135 | 1140 | SSYQLI | 12 | ||||
2015 | F1R294 | 1178 | 1183 | PDYVLV | 15 | Q8MQJ7_DROME(389-394) DDFVLV(4); ULK2_HUMAN(351-356) DDFVLV(4) |
helicase activity (GO:0004386) |
||
2016 | F1R2A7 | 384 | 389 | FSFVAI | 12 | OPTN_HUMAN(176-181) DSFVEI(4) | |||
2017 | F1R2C7 | 356 | 361 | GVYEPV | 7 | ||||
2018 | F1R2I7 | 565 | 570 | LSFELL | 10 | ||||
2019 | F1R2I7 | 793 | 798 | EDYIII | 17 | NBR1_HUMAN(730-735) EDYIII(6); TBC25_HUMAN(134-139) EDWDII(4) |
|||
2020 | F1R2J9 | 285 | 290 | LTFLLI | 9 | ||||
2021 | F1R2J9 | 420 | 425 | LTYEEV | 11 | Atg19_YEAST(410-415) LTWEEL(4) | |||
2022 | F1R2L3 | 39 | 44 | ADYVML | 18 | ||||
2023 | F1R2N5 | 669 | 674 | AGFLHI | 10 | ||||
2024 | F1R2R4 | 616 | 621 | ETYTKL | 12 | ||||
2025 | F1R2R6 | 133 | 138 | FEYLVV | 13 | ATG1_YEAST(427-432) REYVVV(4) | |||
2026 | F1R2V0 | 661 | 666 | AGFLHI | 10 | amine metabolic process (GO:0009308) |
|||
2027 | F1R2V6 | 56 | 61 | DDFITV | 17 | Q8MQJ7_DROME(389-394) DDFVLV(4); ULK1_HUMAN(355-360) DDFVMV(4); ULK2_HUMAN(351-356) DDFVLV(4) |
|||
2028 | F1R2W2 | 598 | 603 | GSFDFL | 12 | ||||
2029 | F1R306 | 377 | 382 | RVYQKV | 7 | ||||
2030 | F1R322 | 432 | 437 | SVFELL | 8 | ||||
2031 | F1R330 | 77 | 82 | EVYDDV | 8 | ||||
2032 | F1R330 | 106 | 111 | DVYDDI | 11 | ||||
2033 | F1R331 | 551 | 556 | EDFVTL | 17 | nucleic acid binding (GO:0003676); nucleotide binding (GO:0000166) |
nucleus (GO:0005634) |
||
2034 | F1R3A7 | 653 | 658 | LVFVLL | 6 | ||||
2035 | F1R3C6 | 1070 | 1075 | KTYDVL | 13 | ATG4B_HUMAN(6-11) LTYDTL(4) | |||
2036 | F1R3D1 | 201 | 206 | PSYEEV | 12 | extracellular region (GO:0005576) |
|||
2037 | F1R3D9 | 639 | 644 | SMYLPV | 11 | ||||
2038 | F1R3F4 | 11 | 16 | LDWEEI | 22 | Atg19_YEAST(410-415) LTWEEL(4) | |||
2039 | F1R3F9 | 292 | 297 | EDFDDI | 16 | TBC25_HUMAN(134-139) EDWDII(4) | |||
2040 | F1R3G7 | 278 | 283 | RMYTDI | 12 | ||||
2041 | F1R3J7 | 248 | 253 | DSYQSL | 14 | FUND1_HUMAN(16-21) DSYEVL(4) | nucleus (GO:0005634) |
||
2042 | F1R3L1 | 417 | 422 | DTFTSL | 13 | ||||
2043 | F1R3N1 | 346 | 351 | PDYDFL | 17 | CALR_HUMAN(198-203) DDWDFL(4); CLH1_HUMAN(512-517) PDWIFL(4) |
|||
2044 | F1R3T2 | 342 | 347 | EDYLIL | 17 | NBR1_HUMAN(730-735) EDYIII(4) | |||
2045 | F1R3U2 | 224 | 229 | LDFTDL | 13 | ||||
2046 | F1R3V8 | 44 | 49 | AEFEDV | 11 | ||||
2047 | F1R3W6 | 66 | 71 | KDFLHI | 14 | voltage-gated calcium channel complex (GO:0005891) |
|||
2048 | F1R3X0 | 457 | 462 | PSFIVL | 11 | ||||
2049 | F1R3X1 | 180 | 185 | KDFIDV | 13 | ||||
2050 | F1R3X6 | 297 | 302 | ASYELL | 12 | FUND1_HUMAN(16-21) DSYEVL(4) |